Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2009
06/11/2009WO2009070917A1 An oral pharmaceutical composition for treating barythymia
06/11/2009WO2009070916A1 A pharmaceutical composition for treating depression and a preparation process thereof
06/11/2009WO2009070915A1 Pharmaceutical compositions for treating depression and anxiety
06/11/2009WO2009070847A1 Compounds for therapy and diagnosis
06/11/2009WO2009047499A3 Processes for the preparation of paliperidone and pharmaceutically acceptable salts thereof and intermediates for use in the processes
06/11/2009WO2009044006A3 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic acid the pharmaceutically-acceptable esters and salts and solvates thereof for use as medicament
06/11/2009WO2009033818A3 Use of a peptide as a therapeutic agent
06/11/2009WO2009033787A3 Use of a peptide as a therapeutic agent
06/11/2009WO2009033786A3 Use of a peptide as a therapeutic agent
06/11/2009WO2009033759A3 Use of a peptide as a therapeutic agent
06/11/2009WO2009033740A3 Use of a peptide as a therapeutic agent
06/11/2009WO2009033722A3 Use of a octreotide as a therapeutic agent
06/11/2009WO2009033719A3 Use of a deslorelin and mastoparan as a therapeutic agent
06/11/2009WO2008147373A3 Methods and compositions for reducing body weight using an estrogen fatty ester in an oil
06/11/2009US20090149799 Method for chemical modulation of neural activity
06/11/2009US20090149629 Corticotropin releasing factor peptide for use in the treatment of nervous system and hypertensive disorders; (cyclo 31-34)[Ac-Pro4,D-Phe12,Nle18,21,Glu31,Lys34]-sucker urotensin
06/11/2009US20090149544 Alpha-aminoamide derivatives
06/11/2009US20090149542 Administering 2-hydroxy-5-(2-(4-trifluoromethyl-phenyl)ethylamino)-benzoic acid
06/11/2009US20090149530 Antiinfective Flavonol Compounds and Methods of Use Thereof
06/11/2009US20090149524 N-(Phenylmethyl)-2-(1H-Pyrazol-4-yl) Acetamide Derivatives as P2X7 Antagonists for the Treatment of Pain, Inflammation and Neurodegeneration
06/11/2009US20090149523 Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases
06/11/2009US20090149513 Compositions of an Orally Active 1,2,4-Oxadiazole for Nonsense Mutation Suppression Therapy
06/11/2009US20090149512 Use of Ghrelin Antagonists to the Treatment of Certain CNS Diseases
06/11/2009US20090149505 Metabotropic Glutamate Receptor-Potentiating Isoindolones
06/11/2009US20090149496 Inhibitors of the task-1 and task-3 ion channel
06/11/2009US20090149495 Compounds
06/11/2009US20090149494 THERAPEUTIC USE OF IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES
06/11/2009US20090149488 Tetrahydroprotoberberine Compounds, the Synthetic Method and the Use Thereof
06/11/2009US20090149485 Pyrimidinediones as tyrosine kinase inhibitors
06/11/2009US20090149475 Thioxanthine Derivatives and Their Use as Inhibitors of MPO
06/11/2009US20090149472 Salts of substitutted pyrazoline compounds, their preparation and use and medicaments
06/11/2009US20090149464 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
06/11/2009US20090149463 Therapeutic agents
06/11/2009US20090149460 New Compounds
06/11/2009US20090149459 P38 inhibitors and methods of use thereof
06/11/2009US20090149457 1H-Thieno[2,3-c]Pyrazole Compounds Useful as Kinase Inhibitors
06/11/2009US20090149450 Substituted imidazoheterocycles
06/11/2009US20090149446 Compositions Comprising Nicotinic Agonists and Methods of Using Same
06/11/2009US20090149445 Tricyclic steroid hormone nuclear receptor modulators
06/11/2009US20090149444 Benzylamine analogues
06/11/2009US20090149442 Atypical antipsychotic agents having low affinity for the D2 receptor
06/11/2009US20090149441 DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDES, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS
06/11/2009US20090149439 Pyridylmethysulfone derivative
06/11/2009US20090149436 Caspase inhibitor
06/11/2009US20090149394 Use of effectors of glutaminyl and glutamate cyclases
06/11/2009US20090149392 Abuse-resistant amphetamine prodrugs
06/11/2009US20090149385 Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration
06/11/2009US20090149378 Glp-1 analogues
06/11/2009US20090148855 Nucleic acid encoding or targeting sodium channel scn3a alpha subunits
06/11/2009US20090148517 Melt-extrusion multiparticulates
06/11/2009US20090148463 Ivig modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's disease
06/11/2009US20090148451 Therapeutic anti-cytomegalovirus compounds
06/11/2009US20090148450 ATF4 As A Therapeutic Target In Alzheimers Disease And Other Neurological Disorders
06/11/2009US20090148436 Antibody to gdf8 and uses thereof
06/11/2009US20090148417 Carbon nanotubes serving as stem cell scaffold
06/11/2009CA2746663A1 Pharmaceutical compositions with a mechanism of multi-target receptor retroaction for treating depression
06/11/2009CA2708022A1 Tricyclic triazolic compounds
06/11/2009CA2707821A1 Isoxazolo-pyridazine derivatives
06/11/2009CA2707722A1 Gamma secretase modulators
06/11/2009CA2707712A1 Gamma secretase modulators
06/11/2009CA2707671A1 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases
06/11/2009CA2707669A1 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
06/11/2009CA2707667A1 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
06/11/2009CA2707666A1 Systems and methods for delivery of materials
06/11/2009CA2707648A1 Isoxazolo-pyridine derivatives
06/11/2009CA2707192A1 Antimelancholic medicine prepared with jujube camp materials
06/11/2009CA2707114A1 Pharmaceutical compositions for treating depression and anxiety
06/11/2009CA2706990A1 Isoxazolo-pyrazine derivatives
06/11/2009CA2706420A1 Compounds for therapy and diagnosis
06/10/2009EP2067863A2 Methods and compositions for diseases associated with amyloidosis
06/10/2009EP2067775A1 Synthesis of UDP-glucose: N-Acylsphingosine glucosyltransferase inhibitors
06/10/2009EP2067772A2 Dibenzo [b,f] azepine intermediates and their preparation
06/10/2009EP2067488A1 Albumin fusion proteins
06/10/2009EP2066685A2 Novel 2',3'-methylidene acetyl adenosine prodrugs for use as prodrugs for adenosine receptor agonists
06/10/2009EP2066680A1 Triphenylphosphonium thionitrite nitric oxide donors
06/10/2009EP2066663A1 Heterocyclic fxr binding compounds
06/10/2009EP2066648A1 Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments
06/10/2009EP2066641A1 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
06/10/2009EP2066636A1 5-phenyl-nicotinamide derivatives
06/10/2009EP2066630A1 Piperidine derivatives
06/10/2009EP2066621A1 Synthesis, polymorphs, and pharmaceutical formulation of a faah inhibitor
06/10/2009EP2066355A2 Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
06/10/2009EP2066335A1 Cytokine signaling
06/10/2009EP2066333A2 Valerian extract preparation
06/10/2009EP2066324A2 Cycloalkanopyrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
06/10/2009EP2066323A2 Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein
06/10/2009EP2066322A2 Hydrogenated pyrido [4,3-b] indoles such as dimebon for treating canine cognitive dysfunction syndrome
06/10/2009EP2066314A2 Use of theogallin for the treatment of mental concentration disorders, depression and dementia
06/10/2009EP2066186A1 Green tea extract, especially for use as a functional food item, food supplement or corresponding ingredient, the use thereof and method for producing said green tea extract
06/10/2009EP1730144B1 Substituted 1,4,8-triazaspiro¬4.5 decan-2-one compounds
06/10/2009EP1599461B1 THIOLACTONES AS NAALADase INHIBITORS
06/10/2009EP1532105B1 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof
06/10/2009EP1385490B1 Adhesive emulsion for medical purposes made from ethylene-vinyl acetate copolymers and adhesive resins
06/10/2009EP1383869B1 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom
06/10/2009EP1115421B1 Use of glp-1 or analogs in treatment of stroke
06/10/2009EP0732924B1 Tts containing a parasympathomimetic and a parasympatholytic agent
06/10/2009DE102005014334B4 Sedativum umfassend Myrrhe, Süßholzwurzel und Wein Sedative comprising myrrh, licorice root and wine
06/10/2009CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase
06/10/2009CN101450212A Solid pharmaceutical dispersions with enhanced bioavailability
06/10/2009CN101450057A Use of oxicam compounds
1 ... 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 ... 1833